Abstract
An efficient green synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones (DHPMs) using MgO/ZrO2 as heterogeneous basic catalyst from an aldehyde, β-keto ester and urea/thiourea under solvent-free conditions is described. A variety of aldehydes were studied with β-keto ester and urea/thiourea giving good to excellent yield of corresponding 3,4-dihydropyrimidin-2-(1H)-ones/thiones. This protocol has advantage of excellent yield, reusability, inexpensive and short reaction time at room temperature. The synthesized catalyst can be reused up to 5 consecutive cycles without any decrease in the yield.
Keywords: DHPMs, green synthesis, multicomponent reactions (MCRs), MgO-ZrO2, medicinal chemistry, alkaloids, Biginelli dihydropyrimidinones, Hantzsh type, batzelladine, anticancer drugs
Letters in Organic Chemistry
Title: A One Pot Green Synthesis of 3,4 Dihydropyrimidin-2-(1H)-ones/Thiones Catalyzed By MgO-ZrO2 Under Solvent-Free Conditions
Volume: 9 Issue: 1
Author(s): Manoj B. Gawande, Deepak M. Nagrik and Damodar M. Ambhore
Affiliation:
Keywords: DHPMs, green synthesis, multicomponent reactions (MCRs), MgO-ZrO2, medicinal chemistry, alkaloids, Biginelli dihydropyrimidinones, Hantzsh type, batzelladine, anticancer drugs
Abstract: An efficient green synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones (DHPMs) using MgO/ZrO2 as heterogeneous basic catalyst from an aldehyde, β-keto ester and urea/thiourea under solvent-free conditions is described. A variety of aldehydes were studied with β-keto ester and urea/thiourea giving good to excellent yield of corresponding 3,4-dihydropyrimidin-2-(1H)-ones/thiones. This protocol has advantage of excellent yield, reusability, inexpensive and short reaction time at room temperature. The synthesized catalyst can be reused up to 5 consecutive cycles without any decrease in the yield.
Export Options
About this article
Cite this article as:
B. Gawande Manoj, M. Nagrik Deepak and M. Ambhore Damodar, A One Pot Green Synthesis of 3,4 Dihydropyrimidin-2-(1H)-ones/Thiones Catalyzed By MgO-ZrO2 Under Solvent-Free Conditions, Letters in Organic Chemistry 2012; 9 (1) . https://dx.doi.org/10.2174/157017812799303980
DOI https://dx.doi.org/10.2174/157017812799303980 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial
Current Medical Imaging Colloidal Polymeric Nanoparticles and Brain Drug Delivery
Current Drug Delivery Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms
Current Medicinal Chemistry Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation Recent Advances on Neural Tube Defects with Special Reference to Valproic Acid
Endocrine, Metabolic & Immune Disorders - Drug Targets Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry Characterisation of a Neural Teratogenicity Assay Based on Human ESCs Differentiation Following Exposure to Valproic Acid
Current Medicinal Chemistry An Insight into the New Anticonvulsant Agents
Current Topics in Medicinal Chemistry Natural Antioxidants: Therapeutic Prospects for Cancer and Neurological Diseases
Mini-Reviews in Medicinal Chemistry MicroRNAs as Biomarkers for Birth Defects
MicroRNA The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
Current Medicinal Chemistry Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives
Letters in Drug Design & Discovery Immunological Mechanisms of Neuropsychiatric Lupus
Current Immunology Reviews (Discontinued) Adeno-Associated Virus (AAV) Vectors in the CNS
Current Gene Therapy The Hippocampal Autophagic Machinery is Depressed in the Absence of the Circadian Clock Protein PER1 that may Lead to Vulnerability During Cerebral Ischemia
Current Neurovascular Research Capillary Electrophoresis Interfaced with a Mass Spectrometer (CE-MS): Technical Considerations and Applicability for Biomarker Studies in Animals
Current Protein & Peptide Science Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) In Vivo MRI in Different Models of Experimental Epilepsy
Current Drug Targets Metabotropic Glutamate Receptors Modulate Periaqueductal Grey Descending Analgesic System
Central Nervous System Agents in Medicinal Chemistry